Cited by 279Mass Spectrometry Techniques and ApplicationsMetabolomics and Mass Spectrometry StudiesIon-surface interactions and analysis

Mass spectrometry imaging for drug distribution studies

Prideaux, Brendan, Stoeckli, Markus·2012·Journal of Proteomics

Abstract

Since its introduction mass spectrometry imaging (MSI) has proven to be a powerful tool for the localization of molecules in biological tissues. In drug discovery and development, understanding the distribution of both drug and its metabolites is of critical importance. Traditional methods suffer from a lack of spatial information (tissue extraction followed by LCMS) or lack of specificity resulting in the inability to resolve parent drug from its metabolites (whole body autoradiography). MSI is a sensitive and label-free approach for imaging drugs and metabolites in tissues. In this article we review the different MSI technologies that have been applied to the imaging of pharmaceuticals. Recent technical advances, applications and current analytical limitations are discussed.

Integrity signals

Registry

Crossref · 10.1016/j.jprot.2012.07.028

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Prideaux, B., & Stoeckli, M.
Affiliations
  • Novartis (Switzerland) (CH)
  • Novartis Institutes for BioMedical Research (CH)
Corresponding author
Prideaux, Brendan
Venue
Journal of Proteomics
Publisher
Elsevier BV
Published
2012-08
Volume
75
Issue
16
Pages
4999-5013
ISSN
1874-3919 (ISSN-L)
OpenAlex
W2044101419
Cited by
279
References
108
Citations by year
2026: 6 · 2025: 6 · 2024: 15 · 2023: 11 · 2022: 18 · 2021: 25 · 2020: 18 · 2019: 19 · 2018: 20 · 2017: 23 · 2016: 32 · 2015: 24 · 2014: 36 · 2013: 23 · 2012: 1
FWCI
2.53
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Proteomics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Novartis Institutes for BioMedical Research
  • National Institute of Allergy and Infectious Diseases
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Physical Sciences › Engineering › Computational Mechanics › Ion-surface interactions and analysis
Keywords
mass spectrometry imaging, drug distribution, drug metabolites, tissue localization, pharmaceuticals, label-free imaging, spatial resolution, drug discovery
MeSH terms
Animals, Biological Availability, Diagnostic Imaging, Pharmaceutical Preparations, Humans, Models, Biological, Mass Spectrometry, Tissue Distribution, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Drug Discovery, High-Throughput Screening Assays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review